N-Acetylcysteine Treatment for Acute Fatty Liver of Pregnancy

Acute fatty liver of pregnancy (AFLP) is a life-threatening disease for both mothers and the baby presented with failure. Although early recognition prompt delivery (the best maternal survival rate when interval from occurrence AFLP to one week), stabilization in intensive care setting supportive therapy ideal. Still, effective treatment failure unknown. For diagnosis, high bilirubin levels, low platelet count, coagulopathy, renal impairment were used as Swansea criteria. usually observed after 30 weeks gestation. In our case, N-acetylcysteine (NAC) was AFLP, results are discussed. Maternal achieved uneventfully quickly. NAC further studies needed.